Aragen scales Renaissance Pharma’s cancer antibody to commercial GMP in just 9 months

Anti-GD2 monoclonal antibody for high-risk neuroblastoma advances toward BLA submission following successful tech transfer from California to Bengaluru

Insect biotech as India's next deeptech opportunity: Ankit Alok Bagaria, Co-founder and CEO, Loopworm

We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms

Pfizer and Innovent Biologics strike $10 billion cancer drug deal

This alliance, covering up to 12 antibody drugs, highlights the growing trend of large-scale collaborations between Chinese biotech firms and global pharmaceutical giants

FDA clears Cercare Medical’s CBCT perfusion technology for real-time stroke imaging

The technology enables clinicians to assess brain tissue and microvascular reperfusion directly in the angiography suite, potentially improving stroke treatment decisions and patient outcomes

Supreme Court declares right to trauma care part of Article 21 in landmark judgement

The ruling comes against the backdrop of a mounting trauma burden in India, where nearly 4.67 lakh accidental deaths occur annually

Remidio’s InstaEyeClinic wins first position at Andhra Pradesh MedTech Innovation Challenge

The device screens for conditions like diabetic retinopathy, glaucoma, age-related macular degeneration, cataract and refractive error, in under ten minutes per patient

Biopharma firms must diversify CDMO partnerships to avoid costly delays: Shilpa Biologicals MD

Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress

HealthTech future will be defined by partnerships grounded in trust: Dr. Sabine Kapasi, CEO, Enira Consulting and Founder of ROPAN Healthcare

India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time

Fredun FY26 profit jumps 60% as revenue hits Rs. 639 Cr

Multimodal AI emerges as next leap in predictive healthcare: Ashwattha Sahasrabuddhe, Principal Architect and Technology & Practice Head – Healthcare Business, Tata Elxsi

Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond